Search Within

Juliet N Barker

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (103)
  2. Journal Article (57)
  3. Research Letter (2)
Groups
  1. Biostatistics Service (162)
  2. Bone Marrow Transplant (162)
  3. Center for Hematologic Malignancies (162)
  4. Department of Medicine (162)
  5. Epidemiology and Biostatistics (162)
  6. Hematologic Malignancies, Division of (162)

More Groups

People
  1. Sergio Giralt (138)
  2. Sean Devlin (135)
  3. Miguel-Angel Perales (119)
  4. Doris Ponce (111)
  5. Esperanza Papadopoulos (96)
  6. Ann Jakubowski (82)

More People

Years
  1. 2024 (2)
  2. 2023 (7)
  3. 2022 (8)
  4. 2021 (2)
  5. 2020 (18)
  6. 2019 (10)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (76)
  2. Blood (42)
  3. Bone Marrow Transplantation (18)
  4. Blood Advances (6)
  5. Transplantation and Cellular Therapy (5)
  6. Leukemia and Lymphoma (4)

More Publications

Publishers
  1. Elsevier Inc. (81)
  2. American Society of Hematology (48)
  3. Nature Publishing Group (19)
  4. Taylor & Francis Group (4)
  5. American Society for Clinical Investigation (2)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (162)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies
    Journal Article

    Dahi, P. B.; Barone, J.; Devlin, S. M.; Byam, C.; Lubin, M.; Ponce, D. M.; Giralt, S.; Kernan, N. A.; Scaradavou, A.; Hsu, S. H.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients
    Journal Article

    Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute GVHD without increased toxicity in double-unit cord blood transplantation (CBT) recipients
    Meeting Abstract

    Harnicar, S. J.; Ponce, D. M.; Gregornik, D.; Mathew, S.; Evans, K. L.; Zheng, J.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Prospective evaluation of alternative donor availability in 708 patients: Improved allograft access with enlarging CB inventory for all patients including racial and ethnic minorities
    Meeting Abstract

    Dahi, P. B.; Ponce, D. M.; Byam, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Gonzales, A. M. R.; Sideroff, M.; Wells, D.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)
    Meeting Abstract

    Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cell-selected PBSC results in 100% CB engraftment with enhanced myeloid recovery
    Meeting Abstract

    Barker, J. N.; Ponce, D. M.; Dahi, P. B.; Devlin, S.; Evans, K. L.; Lubin, M. N.; Meagher, R.; Reich, L.; Castro-Malaspina, H.; Goldberg, J. D.; more...
    Blood (2013)

    Fulltext@MSK | Save